Ramiprilat

This classification denotes an ace inhibitor with the molecular formula C21H28N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6N5U4QFC3G, chemically known as (2s,3as,6as)-1-((s)-n-((s)-1-carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid but generally known as ramiprilat, which bears US NIH Compound Identifier 5464096. European Medicines Agency schedules Ramiprilat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10249MIG. The term RAMIPRILAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). RAMIPRILAT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ramiprilat under HS 29339990 and SITC 51577. As of Q4 2014, RAMIPRILAT remains the US FDA Preferred Term for this commodity. Ramiprilat bears US NLM identifiers UMLS ID C0072970 and NCI Concept Code C72911. SMILES: O=C(N1C2C(CC1C(=O)O)CCC2)C(NC(CCc1ccccc1)C(=O)O)C.